BLACKSBURG, Virginia, Sept. 3 (TNSjou) -- Virginia Tech issued the following news:

* * *

Blocking a microRNA reverses deadly lung disease in preclinical study

Researchers identified microRNA-224 as a promising, first-in-class treatment target for pulmonary arterial hypertension, a rare disease that damages the blood vessels in the lungs.

By John Pastor

Researchers blocked a naturally occurring molecule to reverse pulmonary arteria . . .

Click here for more information about our products